Skip to main content
Top
Published in: Endocrine 2/2012

01-04-2012 | Original Article

Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese spanish children and adolescents

Authors: M. P. Bahíllo-Curieses, F. Hermoso-López, M. J. Martínez-Sopena, P. Cobreros-García, P. García-Saseta, M. Tríguez-García, J. M. Marugán-Miguelsanz

Published in: Endocrine | Issue 2/2012

Login to get access

Abstract

The prevalence of obesity in children has increased in developed countries in the last decades. It is associated with alterations in glucose metabolism that may be present in childhood. To assess the frequency of glucose metabolism alterations and insulin resistance and their possible determinants in a sample of obese children from Valladolid (Spain), we retrospectively studied 100 obese children and adolescents (11.59 ± 2.73 years). Anthropometric measures, biochemical parameters, and oral glucose tolerance test (OGTT) were performed. Insulin resistance was evaluated with fasting insulin, HOMA index, and insulin values in OGTT. Impaired glucose tolerance was found in 15% of the sample, and was the most frequent of glucose metabolism alterations. Impaired fasting glucose was found in 2%. No case of type 2 diabetes was found. Acanthosis nigricans was present in 22%, with predominance in females, but not all presented insulin resistance. The prevalence of insulin resistance was 29% when HOMA index was used, and 50% when the insulin response in OGTT was used. Not all patients with impaired glucose tolerance had a pathological HOMA index, and not all with pathological HOMA index presented insulin resistance when insulin values in OGTT were used. Higher 2-h post-OGTT insulin levels were found in children with impaired glucose tolerance. It is paramount to identify young people with glucose regulation alterations for early, intensive intervention to prevent or at least postpone the onset of type 2 diabetes. OGTT is a screening tool necessary to fulfill this objective.
Literature
1.
go back to reference E. Felszeghy, E. Juhasz, Alterations of glucoregulation in childhood obesity-association with insulin resistance and hyperinsulinemia. J. Pediatr. Endocrinol. Metabol. 21, 847–853 (2008)CrossRef E. Felszeghy, E. Juhasz, Alterations of glucoregulation in childhood obesity-association with insulin resistance and hyperinsulinemia. J. Pediatr. Endocrinol. Metabol. 21, 847–853 (2008)CrossRef
2.
go back to reference S. Garnett, S. Srinivasant, S. Birtt, R. Ambler, E. Lawrie, C. Cowell, M. Craig, Evaluation of glycaemic status in young people with clinical insulin resistance, fasting glucose, fasting insulin or an oral glucose tolerance test? Clin. Endocrinol (Oxf). 72, 475–480 (2010)CrossRef S. Garnett, S. Srinivasant, S. Birtt, R. Ambler, E. Lawrie, C. Cowell, M. Craig, Evaluation of glycaemic status in young people with clinical insulin resistance, fasting glucose, fasting insulin or an oral glucose tolerance test? Clin. Endocrinol (Oxf). 72, 475–480 (2010)CrossRef
3.
go back to reference Carrascosa-Lezcano A, Fernández-García JM, Fernández-Ramos C, Ferrández Longas A, López-Siguero JP, Sánchez-González E, Sobradillo-Ruiz B, Yeste-Fernández y Grupo Colaborador Español. Estudio transversal español de crecimiento 2008. Parte II: valores de talla, peso e índice de masa corporal desde el nacimiento hasta la talla adulta. An. Pediatr(Barc). 68, 544–551(2008) Carrascosa-Lezcano A, Fernández-García JM, Fernández-Ramos C, Ferrández Longas A, López-Siguero JP, Sánchez-González E, Sobradillo-Ruiz B, Yeste-Fernández y Grupo Colaborador Español. Estudio transversal español de crecimiento 2008. Parte II: valores de talla, peso e índice de masa corporal desde el nacimiento hasta la talla adulta. An. Pediatr(Barc). 68, 544–551(2008)
4.
go back to reference M. Hernández, J. Castellet, J.L. Narvaiza, J.M. Rincón, I. Ruiz, E. Sanchez et al., Curvas y tablas de crecimiento. Instituto de Investigación sobre Crecimiento y Desarrollo, Fundación Faustino Orbegozo (Editorial Garsi. Fundación Orbegozo, Madrid, 1988) M. Hernández, J. Castellet, J.L. Narvaiza, J.M. Rincón, I. Ruiz, E. Sanchez et al., Curvas y tablas de crecimiento. Instituto de Investigación sobre Crecimiento y Desarrollo, Fundación Faustino Orbegozo (Editorial Garsi. Fundación Orbegozo, Madrid, 1988)
5.
go back to reference T.J. Cole, M.C. Bellizzi, K.M. Flegal, W.H. Dietz, Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320, 1240–1243 (2000)PubMedCrossRef T.J. Cole, M.C. Bellizzi, K.M. Flegal, W.H. Dietz, Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320, 1240–1243 (2000)PubMedCrossRef
7.
go back to reference American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl I), S62–S69 (2010)CrossRef American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl I), S62–S69 (2010)CrossRef
8.
9.
go back to reference García-Cuartero B, García-Lacalle C, Jiménez-Lobo C, González-Vergaz A, Calvo-Rey C, Alcázar-Villar MJ, Díaz-Martínez E. The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children. An. Pediatr (Barc). 66(5), 481–490 (2007) García-Cuartero B, García-Lacalle C, Jiménez-Lobo C, González-Vergaz A, Calvo-Rey C, Alcázar-Villar MJ, Díaz-Martínez E. The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children. An. Pediatr (Barc). 66(5), 481–490 (2007)
10.
go back to reference A.M. Cali, S. Caprio, Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? Curr. Opin. Endocrinol. Diabetes. Obes. 15, 123–127 (2008)PubMedCrossRef A.M. Cali, S. Caprio, Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? Curr. Opin. Endocrinol. Diabetes. Obes. 15, 123–127 (2008)PubMedCrossRef
11.
go back to reference D. Yeste, S. Betancourth, M. Gussinyé, N. Potau, A. Carrascosa, Intolerancia a la glucose en niños y adolescentes obesos. Med. Clin (Barc). 125(11), 405–408 (2005)CrossRef D. Yeste, S. Betancourth, M. Gussinyé, N. Potau, A. Carrascosa, Intolerancia a la glucose en niños y adolescentes obesos. Med. Clin (Barc). 125(11), 405–408 (2005)CrossRef
12.
go back to reference M.G. Guijarro, S. Monereo, S. Civantos, J.M. Montaño, P. Iglesias, M. Durán, Prevalencia de alteraciones del metabolismo hidrocarbonado en una población infanto-juvenil con obesidad grave. Endocrinol. Nutr. 57(10), 467–471 (2010)CrossRef M.G. Guijarro, S. Monereo, S. Civantos, J.M. Montaño, P. Iglesias, M. Durán, Prevalencia de alteraciones del metabolismo hidrocarbonado en una población infanto-juvenil con obesidad grave. Endocrinol. Nutr. 57(10), 467–471 (2010)CrossRef
13.
go back to reference G. Bueno, L.A. Moreno, O. Bueno, J. Morales, T. Pérez-Roche, J.M. Garagorri, M. Bueno, Metabolic risk-factors clustering estimation in obese children. J. Physiol. Biochem. 63(4), 347–356 (2007)PubMedCrossRef G. Bueno, L.A. Moreno, O. Bueno, J. Morales, T. Pérez-Roche, J.M. Garagorri, M. Bueno, Metabolic risk-factors clustering estimation in obese children. J. Physiol. Biochem. 63(4), 347–356 (2007)PubMedCrossRef
14.
go back to reference E. Felszeghy, R. Kaposzta, E. Juhász, L. Kardos, L. Ilyés, Alterations of carbohydrate and lipoprotein metabolism in childhood obesity-Impact of insulin resistance and acanthosis nigricans. J. Pediatr. Endocrinol. Metabol. 22, 1117–1126 (2009)CrossRef E. Felszeghy, R. Kaposzta, E. Juhász, L. Kardos, L. Ilyés, Alterations of carbohydrate and lipoprotein metabolism in childhood obesity-Impact of insulin resistance and acanthosis nigricans. J. Pediatr. Endocrinol. Metabol. 22, 1117–1126 (2009)CrossRef
15.
go back to reference R. Ghergherechi, A. Tabrizi, Prevalence of impaired glucose tolerance and insulin resistance among obese children and adolescents. Ther. Clin. Risk. Manag. 6, 345–349 (2010)PubMedCrossRef R. Ghergherechi, A. Tabrizi, Prevalence of impaired glucose tolerance and insulin resistance among obese children and adolescents. Ther. Clin. Risk. Manag. 6, 345–349 (2010)PubMedCrossRef
16.
go back to reference S. Shalitin, M. Abrahami, P. Lilos, M. Phillip, Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int. J. Obes. 29, 571–578 (2005)CrossRef S. Shalitin, M. Abrahami, P. Lilos, M. Phillip, Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int. J. Obes. 29, 571–578 (2005)CrossRef
17.
go back to reference G. Valerio, M.R. Licenziati, A. Iannuzzi, A. Franzese, P. Siani, G. Riccardi, P. Rubba, Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr. Metab. Cardiovasc. Dis. 16, 279–284 (2006)PubMedCrossRef G. Valerio, M.R. Licenziati, A. Iannuzzi, A. Franzese, P. Siani, G. Riccardi, P. Rubba, Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr. Metab. Cardiovasc. Dis. 16, 279–284 (2006)PubMedCrossRef
18.
go back to reference V. Cambuli, M. Incani, S. Pilia, T. Congiu, M.G. Cavallo, E. Cossu, F. Sentinelli, S. Mariotti, S. Loche, M. Baroni, Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes. Diabetes. Metab. Res. Rev. 25, 528–534 (2009)PubMedCrossRef V. Cambuli, M. Incani, S. Pilia, T. Congiu, M.G. Cavallo, E. Cossu, F. Sentinelli, S. Mariotti, S. Loche, M. Baroni, Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes. Diabetes. Metab. Res. Rev. 25, 528–534 (2009)PubMedCrossRef
19.
go back to reference C. Brufani, P. Ciampalini, A. Grossi, R. Fiori, D. Fintini, A. Tozzi, M. Cappa, F. Barbetti, Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. Pediatr. Diabetes. 11, 47–54 (2010)PubMedCrossRef C. Brufani, P. Ciampalini, A. Grossi, R. Fiori, D. Fintini, A. Tozzi, M. Cappa, F. Barbetti, Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. Pediatr. Diabetes. 11, 47–54 (2010)PubMedCrossRef
20.
go back to reference R. Sinha, G. Fish, B. Teague, W. Tamborlane, B. Banyas, Prevalence o impaired glucose tolerance among children and adolescents with marked obesity. N. Engl. J. Med. 346, 802–810 (2002)PubMedCrossRef R. Sinha, G. Fish, B. Teague, W. Tamborlane, B. Banyas, Prevalence o impaired glucose tolerance among children and adolescents with marked obesity. N. Engl. J. Med. 346, 802–810 (2002)PubMedCrossRef
21.
go back to reference C. Maffeis, L. Pinelli, P. Brambilla, C. Banzato, L. Valzolgher, D. Ulmi, S. Di Candia, B. Cammarata, A. Morandi, Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity 18, 1437–1442 (2010)PubMedCrossRef C. Maffeis, L. Pinelli, P. Brambilla, C. Banzato, L. Valzolgher, D. Ulmi, S. Di Candia, B. Cammarata, A. Morandi, Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity 18, 1437–1442 (2010)PubMedCrossRef
22.
go back to reference M.H. Moadab, R. Kelishadi, M. Hashemipour, M. Amini, P. Poursafa, The prevalence of impaired fasting glucose and type 2 diabetes in a population-based sample of overweight/obese children in the Middle East. Pediatr. Diabetes. 11, 101–106 (2010)PubMedCrossRef M.H. Moadab, R. Kelishadi, M. Hashemipour, M. Amini, P. Poursafa, The prevalence of impaired fasting glucose and type 2 diabetes in a population-based sample of overweight/obese children in the Middle East. Pediatr. Diabetes. 11, 101–106 (2010)PubMedCrossRef
23.
go back to reference C. Levy-Marchal, S. Arslanian, W. Cutfield, A. Sinaiko, C. Druet, M. Loredana, F. Chiarielli, Insulin Resistance in children: consensus, perspective and future directions. J. Clin. Endocrin. Metab. 95, 1–10 (2010)CrossRef C. Levy-Marchal, S. Arslanian, W. Cutfield, A. Sinaiko, C. Druet, M. Loredana, F. Chiarielli, Insulin Resistance in children: consensus, perspective and future directions. J. Clin. Endocrin. Metab. 95, 1–10 (2010)CrossRef
24.
go back to reference Wang R, Qiang L, Feng J, Yin F, Qin C, Liu B, Liu Y, Liu X. Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males, Endocr. Jul 28 (2011) (Epub ahead of print) Wang R, Qiang L, Feng J, Yin F, Qin C, Liu B, Liu Y, Liu X. Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males, Endocr. Jul 28 (2011) (Epub ahead of print)
25.
go back to reference Y. Zhang, X. Lu, J. Hong, M. Chao, W. Gu, W. Wang, G. Ning, Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus. Endocr 38, 181–187 (2010)CrossRef Y. Zhang, X. Lu, J. Hong, M. Chao, W. Gu, W. Wang, G. Ning, Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus. Endocr 38, 181–187 (2010)CrossRef
26.
go back to reference Y. Abe, T. Kikuchi, K. Nagasaki, M. Hiura, Y. Tanaka, Y. Ogawa, M. Uchiyama, Usefulness of GPT for diagnosis of metabolic syndrome in obese Japanese children. J. Atheroscler. Thromb. 16, 902–909 (2009)PubMedCrossRef Y. Abe, T. Kikuchi, K. Nagasaki, M. Hiura, Y. Tanaka, Y. Ogawa, M. Uchiyama, Usefulness of GPT for diagnosis of metabolic syndrome in obese Japanese children. J. Atheroscler. Thromb. 16, 902–909 (2009)PubMedCrossRef
27.
go back to reference Gronbaek H, Lange A, Birkebaek N, Holland-Fischer P, Solvig J, Horlyck A, Kristensen K, Rittig S, Vilstrup H. J. Pediatr. Gastroenterol. Nutr. Jul 12 (2011) (Epub ahead of print) Gronbaek H, Lange A, Birkebaek N, Holland-Fischer P, Solvig J, Horlyck A, Kristensen K, Rittig S, Vilstrup H. J. Pediatr. Gastroenterol. Nutr. Jul 12 (2011) (Epub ahead of print)
28.
go back to reference R. Weiss, Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth. Pediatr. Diabetes. 8, 70–75 (2007)PubMedCrossRef R. Weiss, Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth. Pediatr. Diabetes. 8, 70–75 (2007)PubMedCrossRef
29.
go back to reference M. Kleber, N. Lass, S. Papcke, M. Wabitsch, T. Reinehr, One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet. Med. 27, 516–552 (2010)PubMedCrossRef M. Kleber, N. Lass, S. Papcke, M. Wabitsch, T. Reinehr, One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet. Med. 27, 516–552 (2010)PubMedCrossRef
30.
go back to reference R. Weiss, S. Taksali, W. Tamborlane, T. Burgert, M. Savoye, S. Caprio, Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28, 902–909 (2005)PubMedCrossRef R. Weiss, S. Taksali, W. Tamborlane, T. Burgert, M. Savoye, S. Caprio, Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28, 902–909 (2005)PubMedCrossRef
Metadata
Title
Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese spanish children and adolescents
Authors
M. P. Bahíllo-Curieses
F. Hermoso-López
M. J. Martínez-Sopena
P. Cobreros-García
P. García-Saseta
M. Tríguez-García
J. M. Marugán-Miguelsanz
Publication date
01-04-2012
Publisher
Springer US
Published in
Endocrine / Issue 2/2012
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9540-8

Other articles of this Issue 2/2012

Endocrine 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.